Australian Patent Office Grants Sanofi SA Patent for Substituted N-phenyl-pyrrolidinylmethylpyrrolidine Amides -Australian Government News


Monday, 8 Jul 2013 08:00pm EDT 

Australian Government News reported that Australian Patent Office has granted patent (2008312636) filed by Sanofi SA on October 14, 2008, for Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators. The patent is effective from October 14, 2008, till October 14, 2028. 

Company Quote

82.0
-0.26 -0.32%
30 Jan 2015